Hypertrophic Cardiomyopathy for Professionals
Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder defined by left ventricular (LV) hypertrophy that cannot be explained by another cardiac or systemic disease. Learning more about HCM will ensure you are better able to discuss its impact with your patients.
Patients whose lives have been restricted by HCM may be able to reduce symptoms and comorbidities. Watch this video series to increase your knowledge.
From diagnosis to management and beyond, these HCM podcasts will help you communicate best with your patients.
Learn more on recognizing and evaluating the pathophysiology of hypertrophic cardiomyopathy (HCM) with AHA’s Hypertrophic Cardiomyopathy Clinical Review.
What’s New When It Comes to Diagnosing and Treating Hypertrophic Cardiomyopathy Patients
Watch this video to find out from leading experts as they discuss the impact of the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. Learn the latest on diagnostic and treatment options for patients, including new treatments on the horizon. Advance a new standard of care for patients with HCM.
How much do you know about HCM?
Hypertrophic cardiomyopathy affects up to 1.5 million Americans. Test your knowledge on diagnosing and treating HCM.
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
{{ formCtrl.response.ResponseTitle }}
Results:
You scored: {{ formCtrl.response.Summary.TotalScore }}
12 – 20 Points:
Review the ACC/AHA Hypertrophic Cardiomyopathy guidelines and try one of our HCM Webinars or Podcasts to learn more.
Your Summary
-
Question{{item.Question}}Your Answers•{{answer}}{{item.Tip}}
|
|
Your Summary
|
|
{{++index}}. {{item.Question}}
|
HCM Patients
In speaking with patients who complain of symptoms consistent with HCM, ask if family members have been diagnosed with HCM, or if there is a family history of sudden cardiac arrest or died due to an unknown cardiovascular disease. When patients present with symptoms such as fatigue, fainting, shortness of breath, chest pain or heart palpitations without a known cause, suspect and test for HCM. With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities.
Download this free poster developed in collaboration with HCMA
Print this poster as a discussion guide for conversations with patients. As you talk with your patients use this as an educational tool. Early detection and disease/symptom management may help reduce some of the consequences of HCM and improve outcomes.
With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities.
Hypertrophic Cardiomyopathy - Sudden Cardiac Death Risk Calculator
This calculator is for use in calculating risk of sudden cardiac death in patients with HCM using the 2020 AHA/ACC Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy.
Guidelines-on-the-Go
The Guidelines-on-the-Go App features the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy, plus so much more.
Guidelines and Articles
- 2020 AHA/ACC Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy Circulation. November 2020.
- Hypertrophic Cardiomyopathy 2020 Clinical Update Slide Set (PDF)
- Gersh BJ, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761-2796.
- Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives Evidence for a Change in Paradigm. Circulation, June 2020.
- Cardiomyopathy in Children: Classification and Diagnosis. Circulation, June 2020.
- Maron BJ. Hypertrophic Cardiomyopathy. Circulation. 2002;106:2419-2421.
News
- 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy AHA Science News
- Hypertrophic Cardiomyopathy Guideline Encourages Shared Decision-Making - AHA Press Release
- Hypertrophic Cardiomyopathy Guideline Encourages Shared Decision-Making - AHA Press Release
- Deadly heart problem might not be so deadly AHA News, 2019.
- Genetic testing helps family uncover inherited heart condition AHA News, 2019.
American Heart Association's Hypertrophic Cardiomyopathy Initiative is sponsored by Bristol Myers Squibb.